Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALB | P02768 | 1/20 | 0.68 |
| ▸ | PPARA | Q07869 | 3/20 | 0.63 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.59 |
| ▸ | ALDH2 | P05091 | 7/20 | 0.56 |
| ▸ | MAOA | P21397 | 6/20 | 0.56 |
| ▸ | MAOB | P27338 | 6/20 | 0.56 |
| ▸ | PLA2G4B | P0C869 | 1/20 | 0.56 |
| ▸ | ESR1 | P03372 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7747968 | 1.00 | ALB (0.68) | ALBPPARANR5A1ALDH2MAOA | |
| SCHEMBL2158826 | 1.00 | ALB (0.68) | ALBPPARANR5A1ALDH2MAOA | |
| SCHEMBL2494017 | 0.98 | ALB (0.66) | ALBPPARANR5A1ALDH2MAOA | |
| SCHEMBL1271045 | 0.92 | ESR1 (0.59) | ALBPPARANR5A1ESR1 | |
| SCHEMBL29141429 | 0.92 | PPARA (0.71) | ALBPPARAPLA2G4B | |
| SCHEMBL21073528 | 0.92 | PPARA (0.71) | ALBPPARAPLA2G4B | |
| SCHEMBL31448424 | 0.92 | PPARA (0.71) | ALBPPARAPLA2G4B | |
| SCHEMBL31448470 | 0.90 | PPARA (0.73) | ALBPPARAPLA2G4B | |
| SCHEMBL2468006 | 0.86 | L3MBTL1 (0.69) | ALBPPARANR5A1ESR1 | |
| SCHEMBL25228768 | 0.85 | PPARA (0.72) | ALBPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8372882-B2 | Functionalized phenolic esters and amides and polymers therefrom | BEZWADA BIOMEDICAL, LLC (US) | 2013-02-12 | — | — | US | disclosed |
| US-8372882-B2 | Functionalized phenolic esters and amides and polymers therefrom | BEZWADA BIOMEDICAL, LLC (US) | 2013-02-12 | — | — | US | disclosed |
| US-20110130448-A1 | FUNCTIONALIZED PHENOLIC ESTERS AND AMIDES AND POLYMERS THEREFROM | BEZWADA BIOMEDICAL LLC (US) | 2011-06-02 | — | — | US | disclosed |
| US-20110130448-A1 | FUNCTIONALIZED PHENOLIC ESTERS AND AMIDES AND POLYMERS THEREFROM | BEZWADA BIOMEDICAL LLC (US) | 2011-06-02 | — | — | US | disclosed |
| US-7858077-B2 | Functionalized phenolic esters and amides and polymers therefrom | BEZWADA BIOMEDICAL LLC (US) | 2010-12-28 | — | — | US | disclosed |
| US-7858077-B2 | Functionalized phenolic esters and amides and polymers therefrom | BEZWADA BIOMEDICAL LLC (US) | 2010-12-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110130448-A1 | FUNCTIONALIZED PHENOLIC ESTERS AND AMIDES AND POLYMERS THEREFROM | HAO2, HCAR2, HAAO | ALB 874/4885PPARA 797/4885NR5A1 358/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.